2017 annual financial data
CytomX Therapeutics 2017 Net margin
CytomX Therapeutics 2017 net margin with verified reported values.
Direct answer
Net margin was -60.17%.
Operating income was -46,259,000 USD and net income was -43,099,000 USD.
Operating cash flow was 170,373,000 USD.
Get free CytomX Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 71,623,000 USD
- Operating income
- -46,259,000 USD
- Net income
- -43,099,000 USD
- Operating cash flow
- 170,373,000 USD